About
Antivirals
Areas of Focus
Categories
Small Molecule PharmaceuticalSeattle/Pacific Northwest
Team (14)
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
402
By Phase
PHASE1/PHASE2: 1PHASE2: 2PHASE1: 3
By Status
COMPLETED: 5NOT_YET_RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07198139Lead Sponsor
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus
PHASE1/PHASE2Not yet recruiting
40 participants
Started: Nov 1, 2025 · Completed: Oct 1, 2026
NCT06160531Lead Sponsor
Influenza Viral Challenge Study of CC-42344 in Healthy Participants
PHASE2Completed
78 participants
Started: Nov 25, 2023 · Completed: Jul 18, 2024
NCT05977140Lead Sponsor
CDI-988 Safety Study in Healthy Participants
PHASE1Completed
116 participants
Started: Sep 27, 2023 · Completed: Jul 23, 2025
NCT05202379Lead Sponsor
CC-42344 Safety Study in Healthy Participants
PHASE1Completed
80 participants
Started: Feb 11, 2022 · Completed: Mar 29, 2023
NCT03501550Lead Sponsor
Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)
PHASE2Completed
12 participants
Started: Jun 26, 2018 · Completed: Jun 7, 2019
Locations (1)
Headquarters
Bothell, WA, United States
Map
Loading map...